Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.
Social support a key factor for adherence to multidrug-resistant tuberculosis treatment.
复制标题
DOI：
10.1016/j.ijtb.2017.05.003
复制
发表时间：
2018-01-01
期刊：
影响因子：
--
通讯作者：
Parmar, M
中科院分区：
文献类型：
--
作者：
Deshmukh, R D;Dhande, D J;Parmar, M
背景：耐多药结核病（MDR-TB）正在成为全球主要的公共卫生问题。在耐多药结核病的治疗成功率在地球仪是不令人鼓舞的成功完成耐多药结核病的治疗是具有挑战性的，由于高比例的失访。方法：采用定性方法和扎根理论的方法，进行了深入的访谈与耐多药结核病患者和治疗提供者。社会认知框架的探索作为一种方式来指导理解的因素影响治疗依从性MDR-TB patients.RESULTS：多因素影响患者的决定，坚持MDR-TB治疗。自我激励、对疾病和治疗的认识、咨询支持、家庭支持、营养支持和社会支持是成功治疗的重要驱动力。供应商相关的动机咨询，营养支持，家庭支持和社会支持鼓励治疗adherence.CONCLUSION：为了提高耐多药结核病治疗的依从性，以病人为中心的方法，应考虑在规划层面。有必要制定战略，包括动机咨询，营养补充和社会支持动员治疗的坚持。与会者建议采用一种患者支持小组主导的治疗护理模式，以提高耐多药结核病治疗的依从性和治疗成功率。
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is emerging as a major public health problem globally. Treatment success rates in MDR-TB across the globe are not encouraging as completing MDR-TB treatment successfully is challenging due to high proportion of lost to follow up.METHODS: Using qualitative methods and grounded theory approach, in-depth interviews were conducted with MDR-TB patients and treatment providers. The social cognitive framework was explored as a way to guide understanding of the factors affecting treatment adherence among MDR-TB patients.RESULTS: Multiple factors influenced patient's decision to adhere to MDR-TB treatment. Self-motivation, awareness about disease and treatment, counselling support, family support, nutritional support and social support were important drivers for successful treatment. Providers related that motivational counselling, nutritional support, family support and social support encouraged treatment adherence.CONCLUSION: To improve MDR-TB treatment adherence, a patient-centric approach should be considered at the programmatic level. There is a need to formulate strategy that includes motivational counselling, nutritional supplementation and social support mobilisation for treatment adherence. Participants suggested a Patient Support Group led treatment care model for better adherence and treatment success rates in MDR-TB treatment.